← Leaderboards
Brielle Hayward-Piatkovskyi
University Of Delaware
$143,308
Attributed
$143,308
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $51.8K · FY2020–22$100K$75K$50K$25K$0
'20
'21
'22
Funding mix
By agency
NIH$143,308 · 1
By mechanism
F31$143,308 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Delaware
Same institution · by research overlap
- Aimee Jaramillo-Lambert$2,152,432
- Christine Kiely Rourke$151,766
- Dawn M Elliott$20,642,324
Others in their field
Other Emerging Leaders on “Agonist”
- Julie Ake · National Institute Of Allergy And Infectious Diseases$22,000,000
- Aaron Esser-Kahn · University Of Chicago$13,378,548
- Nikej Shah · Nirsum Laboratories, Inc.$12,506,430
- Xinhua Li · Nano Terra, Inc.$11,941,250
- James Dale Berry · Brigham And Women'S Hospital$9,298,517
- James N Campbell · Centrexion Therapeutics Corporation$8,662,635
Research focus
AgonistAlamarblueAlveolarAngiogenesisBaseBirthBirth WeightBlood VesselsBronchopulmonary DysplasiaCell InjuryCellsCellular Metabolic ProcessChronic Lung DiseaseDefectDependenceDimorphismEndothelial CellsEnvironmentEstradiolEstrogensExposure ToFatty Acid OxidationFemale3-Dimensional
Grant awards (5)
PPARg as a key regulator of sex-based differences in bronchopulmonary dysplasia$46,752
F31 · FY2022 · HL · contact PI
PPARg as a key regulator of sex-based differences in bronchopulmonary dysplasia$2,500
F31 · FY2022 · HL · contact PI
PPARg as a key regulator of sex-based differences in bronchopulmonary dysplasia$2,500
F31 · FY2022 · HL · contact PI
PPARg as a key regulator of sex-based differences in bronchopulmonary dysplasia$46,036
F31 · FY2021 · HL · contact PI
PPARg as a key regulator of sex-based differences in bronchopulmonary dysplasia$45,520
F31 · FY2020 · HL · contact PI